Effect of ADHD medication in male C57BL/6J mice performing the rodent Continuous Performance Test
- 143 Downloads
The rodent Continuous Performance Test (rCPT) is a novel rodent paradigm to assess attention and impulsivity that resembles the human CPT. This task measures the rodents’ ability to discriminate between target and non-target stimuli. The effect of attention-deficit/hyperactivity disorder (ADHD) medication on rCPT performance in mice remains to be fully characterized.
To investigate the predictive validity of the mouse rCPT by studying the effects of ADHD medication methylphenidate, atomoxetine, amphetamine, guanfacine, and modafinil in four behavioral subgroups based on performance and impulsivity levels.
Two cohorts of male C57BL/6J mice were used, and the effect of treatment was tested in a variable stimulus duration probe. Performance and impulsive subgroups were made based on discriminability and percentage premature responses, respectively.
Methylphenidate, atomoxetine, and amphetamine improved performance in the low-performing animals, with no effect in the high-performers. These improvements were a result of increased hit rate and/or decreased false-alarm rate. Furthermore, these drugs decreased percentage premature responses in the high-impulsive group. Methylphenidate, guanfacine, and modafinil increased premature responses in the low-impulsive group. Modafinil impaired performance in the high-performers by increasing false-alarm rate.
The effect of ADHD treatment was dependent on baseline, as seen by increases in performance for the low-performers and decreases in impulsivity for the high-impulsive animals. These results agree with clinical data and may support the inverted U-shaped arousal-performance theory. The rCPT combined with behavioral separation into subgroups has high predictive validity, and our study is a step forward towards establishing the clinical translatability of the rCPT.
KeywordsContinuous performance task Attention-deficit/hyperactivity disorder Touchscreen operant chamber Predictive validity Translatability Methylphenidate d-Amphetamine Atomoxetine Modafinil Guanfacine
The authors will like to thank Lars Arvastson and Simon Bate for their statistical advice.
Compliance with ethical standards
All procedures were approved by the Danish Animal Experiment Inspectorate.
Conflict of interest
The authors declare that they have no conflict of interest.
- Adler LA, Liebowitz M, Kronenberger W, Qiao M, Rubin R, Hollandbeck M, Deldar A, Schuh K, Durell T (2009) Atomoxetine treatment in adults with attention-deficit/hyperactivity disorder and comorbid social anxiety disorder. Depress Anxiety 26:212–221. https://doi.org/10.1002/da.20549 CrossRefPubMedGoogle Scholar
- Bate ST, Clark RA (2015) invivostat.co.uk, 3.4 edn
- Bismark AW, Thomas ML, Tarasenko M, Shiluk AL, Rackelmann SY, Young JW, Light GA (2018) Reverse translated and gold standard continuous performance tests predict global cognitive performance in schizophrenia. Transl Psychiatry 8:80. https://doi.org/10.1038/s41398-018-0127-5 CrossRefPubMedPubMedCentralGoogle Scholar
- Caballero-Puntiverio M, Fitzpatrick CM, Woldbye DP, Andreasen JT (2017) Effects of amphetamine and methylphenidate on attentional performance and impulsivity in the mouse 5-choice serial reaction time task. J Psychopharmacol (Oxford, England) 31:272–283. https://doi.org/10.1177/0269881116684339 CrossRefGoogle Scholar
- Caprioli D, Jupp B, Hong YT, Sawiak SJ, Ferrari V, Wharton L, Williamson DJ, McNabb C, Berry D, Aigbirhio FI, Robbins TW, Fryer TD, Dalley JW (2015) Dissociable rate-dependent effects of oral methylphenidate on impulsivity and D(2/3) receptor availability in the striatum. J Neurosci 35:3747–3755. https://doi.org/10.1523/JNEUROSCI.3890-14.2015 CrossRefPubMedPubMedCentralGoogle Scholar
- Chamberlain SR, Robbins TW, Winder-Rhodes S, Muller U, Sahakian BJ, Blackwell AD, Barnett JH (2011) Translational approaches to frontostriatal dysfunction in attention-deficit/hyperactivity disorder using a computerized neuropsychological battery. Biol Psychiatry 69:1192–1203. https://doi.org/10.1016/j.biopsych.2010.08.019 CrossRefPubMedGoogle Scholar
- Conners CK (2014) Conners’ continuous performance test third edition: Computer program for windows technical guide and software manual. Multi-Health Systems, North TonawandaGoogle Scholar
- Cope ZA, Young JW (2017) The five-choice continuous performance task (5C-CPT): a cross-species relevant paradigm for assessment of vigilance and response inhibition in rodents current protocols in neuroscience / editorial board, Jacqueline N Crawley [et al] 78:9.56.51–59.56.18 https://doi.org/10.1002/cpns.20
- Cope ZA, Minassian A, Kreitner D, MacQueen DA, Milienne-Petiot M, Geyer MA, Perry W, Young JW (2017) Modafinil improves attentional performance in healthy, non-sleep deprived humans at doses not inducing hyperarousal across species. Neuropharmacology 125:254–262. https://doi.org/10.1016/j.neuropharm.2017.07.031 CrossRefPubMedGoogle Scholar
- Fitzpatrick CM, Maric VS, Bate ST, Andreasen JT (2018) Influence of intertrial interval on basal and drug-induced impulsive action in the 5-choice serial reaction time task: effects of d-amphetamine and (+/−)-2,5-dimethoxy-4-iodoamphetamine (DOI). Neurosci Lett 662:351–355. https://doi.org/10.1016/j.neulet.2017.10.058 CrossRefPubMedGoogle Scholar
- Gualtieri CT, Johnson LG (2005) ADHD: is objective diagnosis possible? Psychiatry (Edgmont) 2:44–53Google Scholar
- Horner AE, Heath CJ, Hvoslef-Eide M, Kent BA, Kim CH, Nilsson SRO, Alsiö J, Oomen CA, Holmes A, Saksida LM, Bussey TJ (2013) The touchscreen operant platform for testing learning and memory in rats and mice. Nat Protoc 8:1961–1984. https://doi.org/10.1038/nprot.2013.122 CrossRefPubMedPubMedCentralGoogle Scholar
- Howe WM, Ji J, Parikh V, Williams S, Mocaër E, Trocmé-Thibierge C, Sarter M (2010) Enhancement of attentional performance by selective stimulation of α4β2(*) nAChRs: underlying cholinergic mechanisms. Neuropsychopharmacology 35:1391–1401. https://doi.org/10.1038/npp.2010.9 CrossRefPubMedPubMedCentralGoogle Scholar
- Kim CH, Hvoslef-Eide M, Nilsson SRO, Johnson MR, Herbert BR, Robbins TW, Saksida LM, Bussey TJ, Mar AC (2015) The continuous performance test (rCPT) for mice: a novel operant touchscreen test of attentional function. Psychopharmacology 232:3947–3966. https://doi.org/10.1007/s00213-015-4081-0 CrossRefPubMedPubMedCentralGoogle Scholar
- Koda K, Ago Y, Cong Y, Kita Y, Takuma K, Matsuda T (2010) Effects of acute and chronic administration of atomoxetine and methylphenidate on extracellular levels of noradrenaline, dopamine and serotonin in the prefrontal cortex and striatum of mice. J Neurochem 114:259–270. https://doi.org/10.1111/j.1471-4159.2010.06750.x CrossRefPubMedGoogle Scholar
- Loos M, Staal J, Schoffelmeer AN, Smit AB, Spijker S, Pattij T (2010) Inhibitory control and response latency differences between C57BL/6J and DBA/2J mice in a go/no-go and 5-choice serial reaction time task and strain-specific responsivity to amphetamine. Behav Brain Res 214:216–224. https://doi.org/10.1016/j.bbr.2010.05.027 CrossRefPubMedGoogle Scholar
- Ma ZQ, Hong ZY, Wang WS, Tao F (2012) Pharmacokinetics--pharmacodynamics of modafinil in mice. Yao xue xue bao = Acta Pharm Sin 47:101–104Google Scholar
- Mar AC, Nilsson SRO, Gamallo-Lana B, Lei M, Dourado T, Alsiö J, Saksida LM, Bussey TJ, Robbins TW (2017) MAM-E17 rat model impairments on a novel continuous performance task: effects of potential cognitive enhancing drugs. Psychopharmacology 234:2837–2857. https://doi.org/10.1007/s00213-017-4679-5 CrossRefPubMedPubMedCentralGoogle Scholar
- Mizuno K, Yoneda T, Komi M, Hirai T, Watanabe Y, Tomoda A (2013) Osmotic release oral system-methylphenidate improves neural activity during low reward processing in children and adolescents with attention-deficit/hyperactivity disorder. NeuroImage Clin 2:366–376. https://doi.org/10.1016/j.nicl.2013.03.004 CrossRefPubMedPubMedCentralGoogle Scholar
- Navarra R, Graf R, Huang Y, Logue S, Comery T, Hughes Z, Day M (2008) Effects of atomoxetine and methylphenidate on attention and impulsivity in the 5-choice serial reaction time test. Prog Neuro-Psychopharmacol Biol Psychiatry 32:34–41. https://doi.org/10.1016/j.pnpbp.2007.06.017 CrossRefGoogle Scholar
- Ni HC, Hwang Gu SL, Lin HY, Lin YJ, Yang LK, Huang HC, Gau SS (2016) Atomoxetine could improve intra-individual variability in drug-naive adults with attention-deficit/hyperactivity disorder comparably with methylphenidate: a head-to-head randomized clinical trial. J Psychopharmacol (Oxford, England) 30:459–467. https://doi.org/10.1177/0269881116632377 CrossRefGoogle Scholar
- NICE (2009) Attention deficit hyperactivity disorder: diagnosis and management of ADHD in children, young people and adults. In: NICE clinical guidelines, no. 72. National Collaborating Centre for Mental Health. British Psychological Society (UK), Leicester (UK)Google Scholar
- Paterson NE, Ricciardi J, Wetzler C, Hanania T (2011) Sub-optimal performance in the 5-choice serial reaction time task in rats was sensitive to methylphenidate, atomoxetine and d-amphetamine, but unaffected by the COMT inhibitor tolcapone. Neurosci Res 69:41–50. https://doi.org/10.1016/j.neures.2010.10.001 CrossRefPubMedGoogle Scholar
- Pillidge K, Porter AJ, Dudley JA, Tsai YC, Heal DJ, Stanford SC (2014a) The behavioural response of mice lacking NK(1) receptors to guanfacine resembles its clinical profile in treatment of ADHD. Br J Pharmacol 171:4785–4796. https://doi.org/10.1111/bph.12860 CrossRefPubMedPubMedCentralGoogle Scholar
- Scahill L, Chappell PB, Kim YS, Schultz RT, Katsovich L, Shepherd E, Arnsten AFT, Cohen DJ, Leckman JF (2001) A placebo-controlled study of guanfacine in the treatment of children with tic disorders and attention deficit hyperactivity disorder. Am J Psychiatry 158:1067–1074. https://doi.org/10.1176/appi.ajp.158.7.1067 CrossRefPubMedGoogle Scholar
- Tomlinson A, Grayson B, Marsh S, Harte MK, Barnes SA, Marshall KM, Neill JC (2014) Pay attention to impulsivity: modelling low attentive and high impulsive subtypes of adult ADHD in the 5-choice continuous performance task (5C-CPT) in female rats. Eur Neuropsychopharmacol 24:1371–1380. https://doi.org/10.1016/j.euroneuro.2014.04.008 CrossRefPubMedGoogle Scholar